Last reviewed · How we verify

Folic acid (FA) — Competitive Intelligence Brief

Folic acid (FA) (Folic acid (FA)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B9 / Nutritional supplement. Area: Hematology / Nutritional deficiency.

marketed Vitamin B9 / Nutritional supplement Dihydrofolate reductase (DHFR) pathway; one-carbon metabolism Hematology / Nutritional deficiency Small molecule Live · refreshed every 30 min

Target snapshot

Folic acid (FA) (Folic acid (FA)) — University Hospital, Essen. Folic acid is a B vitamin that acts as a coenzyme in one-carbon transfer reactions essential for DNA synthesis and cell division.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Folic acid (FA) TARGET Folic acid (FA) University Hospital, Essen marketed Vitamin B9 / Nutritional supplement Dihydrofolate reductase (DHFR) pathway; one-carbon metabolism

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B9 / Nutritional supplement class)

  1. University Hospital, Essen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Folic acid (FA) — Competitive Intelligence Brief. https://druglandscape.com/ci/folic-acid-fa. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: